Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Katharine Yao

Concepts (249)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mastectomy
43
2021
228
15.690
Why?
Breast Neoplasms
77
2021
2731
15.020
Why?
Carcinoma, Ductal, Breast
21
2019
158
8.000
Why?
Carcinoma, Lobular
18
2019
80
7.390
Why?
Mastectomy, Segmental
14
2021
91
4.110
Why?
Neoadjuvant Therapy
8
2019
269
3.500
Why?
Neoplasm Staging
25
2019
1900
3.050
Why?
Quality Indicators, Health Care
5
2021
126
2.560
Why?
Lymph Node Excision
10
2021
214
2.430
Why?
Sentinel Lymph Node Biopsy
12
2021
61
2.350
Why?
Cancer Care Facilities
3
2020
25
2.330
Why?
Radiation Oncology
3
2021
110
2.320
Why?
Accreditation
3
2019
51
2.200
Why?
Databases, Factual
18
2018
797
2.180
Why?
Receptors, Estrogen
9
2019
381
2.170
Why?
Prognosis
25
2020
3619
2.130
Why?
Mammaplasty
8
2018
107
2.040
Why?
Middle Aged
61
2021
25178
1.980
Why?
Practice Guidelines as Topic
7
2019
1064
1.960
Why?
Carcinoma, Intraductal, Noninfiltrating
6
2016
111
1.950
Why?
Female
80
2021
43684
1.910
Why?
Guideline Adherence
4
2018
220
1.910
Why?
Neoplasm Recurrence, Local
9
2020
1171
1.870
Why?
Follow-Up Studies
21
2020
3811
1.800
Why?
Radiotherapy, Adjuvant
9
2021
305
1.770
Why?
Chemotherapy, Adjuvant
8
2019
482
1.770
Why?
Aged, 80 and over
33
2018
6483
1.760
Why?
Aged
48
2021
18161
1.720
Why?
Receptor, erbB-2
5
2019
186
1.530
Why?
Humans
87
2021
80482
1.530
Why?
Thoracic Wall
2
2018
21
1.530
Why?
Lymph Nodes
4
2018
524
1.410
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2019
2223
1.400
Why?
Nipples
5
2021
37
1.390
Why?
Decision Support Techniques
2
2019
157
1.320
Why?
Neoplasm Invasiveness
9
2020
529
1.310
Why?
Adult
42
2021
25396
1.290
Why?
United States
25
2021
6119
1.270
Why?
Combined Modality Therapy
8
2021
1637
1.240
Why?
Decision Making
4
2019
615
1.220
Why?
Retrospective Studies
23
2020
7284
1.210
Why?
Axilla
11
2021
98
1.190
Why?
Neoplasms, Second Primary
3
2017
235
1.190
Why?
Breast
6
2021
277
1.190
Why?
Receptors, Progesterone
6
2019
166
1.190
Why?
Survival Rate
12
2018
1933
1.110
Why?
Brachytherapy
2
2014
111
1.040
Why?
Carcinoma
2
2017
431
1.020
Why?
Organ Sparing Treatments
2
2019
34
0.980
Why?
Neoplasm Grading
10
2018
319
0.930
Why?
Attitude of Health Personnel
2
2018
639
0.930
Why?
Quality of Health Care
3
2018
353
0.870
Why?
Burnout, Professional
1
2021
68
0.840
Why?
Healthcare Disparities
2
2015
320
0.800
Why?
Lymphatic Metastasis
7
2018
505
0.780
Why?
Antineoplastic Agents, Hormonal
3
2017
147
0.780
Why?
Stereotaxic Techniques
1
2019
85
0.770
Why?
Age Factors
9
2018
1904
0.770
Why?
Patient Satisfaction
4
2016
422
0.760
Why?
Consensus
2
2016
269
0.740
Why?
Patient Selection
6
2019
687
0.730
Why?
Patient Care
1
2019
86
0.730
Why?
Patient Transfer
1
2018
85
0.730
Why?
Reoperation
5
2015
619
0.730
Why?
Coronavirus Infections
2
2020
283
0.730
Why?
Pneumonia, Viral
2
2020
309
0.720
Why?
Genes, BRCA2
3
2016
147
0.720
Why?
Radiography, Interventional
1
2019
147
0.720
Why?
Genes, BRCA1
3
2016
187
0.710
Why?
Patient Acceptance of Health Care
2
2017
215
0.690
Why?
Mastectomy, Subcutaneous
1
2016
9
0.680
Why?
Young Adult
12
2021
5784
0.680
Why?
Radiotherapy, Conformal
1
2017
87
0.680
Why?
Patient Preference
4
2019
101
0.660
Why?
Logistic Models
7
2017
1158
0.650
Why?
Societies, Medical
2
2019
523
0.640
Why?
Postoperative Complications
7
2016
2242
0.630
Why?
Quality of Life
4
2019
1277
0.610
Why?
Estrogen Receptor alpha
2
2013
134
0.580
Why?
Health Knowledge, Attitudes, Practice
2
2019
517
0.580
Why?
Prospective Studies
7
2021
3903
0.560
Why?
Patient Education as Topic
1
2016
338
0.530
Why?
Cross-Sectional Studies
4
2021
1367
0.510
Why?
Continental Population Groups
1
2015
296
0.500
Why?
Length of Stay
3
2015
685
0.500
Why?
Receptors, Notch
2
2010
119
0.500
Why?
Radiotherapy, Intensity-Modulated
1
2013
161
0.480
Why?
Skin Neoplasms
2
2009
535
0.470
Why?
Melanoma
2
2009
494
0.470
Why?
Registries
1
2014
630
0.450
Why?
Patient Readmission
1
2014
278
0.440
Why?
Receptor, Notch1
2
2010
80
0.440
Why?
Adolescent
7
2021
8911
0.410
Why?
Gelatin Sponge, Absorbable
1
2008
3
0.400
Why?
Breast Diseases
1
2008
97
0.370
Why?
Socioeconomic Factors
3
2016
564
0.370
Why?
Quality Control
2
2019
124
0.360
Why?
Breast Implantation
3
2016
17
0.350
Why?
Calcinosis
1
2008
238
0.340
Why?
Proto-Oncogene Proteins
2
2010
660
0.340
Why?
Pilot Projects
3
2019
801
0.330
Why?
SEER Program
3
2017
194
0.330
Why?
Risk Factors
6
2019
5279
0.320
Why?
Randomized Controlled Trials as Topic
3
2017
844
0.310
Why?
Multivariate Analysis
4
2018
1025
0.310
Why?
Health Care Surveys
2
2018
303
0.290
Why?
Proportional Hazards Models
3
2017
868
0.290
Why?
Risk Assessment
4
2020
2239
0.290
Why?
Magnetic Resonance Imaging
1
2017
3172
0.290
Why?
Referral and Consultation
2
2019
318
0.280
Why?
Biopsy
3
2014
1165
0.260
Why?
Radiotherapy Dosage
2
2014
465
0.250
Why?
Time Factors
5
2016
5437
0.240
Why?
Cohort Studies
4
2018
2626
0.220
Why?
Workload
1
2021
120
0.210
Why?
Operating Rooms
1
2021
112
0.210
Why?
Gene Expression Profiling
2
2019
1355
0.210
Why?
Mammography
2
2017
461
0.210
Why?
Personnel Selection
1
2020
58
0.210
Why?
Specialties, Surgical
1
2020
55
0.200
Why?
Longitudinal Studies
2
2020
951
0.200
Why?
Body Image
1
2019
65
0.200
Why?
Fear
1
2019
66
0.200
Why?
Triage
1
2020
97
0.200
Why?
Health Resources
1
2020
77
0.200
Why?
Fellowships and Scholarships
1
2020
92
0.200
Why?
Breast Implants
2
2016
32
0.200
Why?
Anxiety
1
2021
240
0.200
Why?
Treatment Outcome
5
2018
7692
0.190
Why?
Interviews as Topic
1
2020
328
0.190
Why?
Telemedicine
1
2020
102
0.190
Why?
User-Computer Interface
1
2020
185
0.190
Why?
Video Recording
1
2019
190
0.190
Why?
Neoplasm Micrometastasis
1
2018
4
0.190
Why?
Databases as Topic
1
2018
94
0.190
Why?
Pandemics
2
2020
465
0.190
Why?
Emotions
1
2021
280
0.180
Why?
Patient Participation
1
2019
188
0.180
Why?
Choice Behavior
1
2018
159
0.170
Why?
Heterozygote
2
2016
369
0.170
Why?
Patient Compliance
1
2018
246
0.170
Why?
Sleep
1
2021
421
0.160
Why?
Odds Ratio
1
2018
684
0.160
Why?
Surgical Wound Infection
2
2015
183
0.160
Why?
Ultrasonography, Mammary
1
2017
83
0.160
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
173
0.160
Why?
Ethnic Groups
2
2017
466
0.160
Why?
Watchful Waiting
1
2016
43
0.160
Why?
Esthetics
1
2016
51
0.160
Why?
Disease Management
1
2018
332
0.160
Why?
Male
7
2021
41036
0.160
Why?
Molecular Typing
1
2015
15
0.160
Why?
Comprehension
1
2016
65
0.160
Why?
Illinois
1
2017
449
0.160
Why?
Europe
1
2016
310
0.160
Why?
Pharyngectomy
1
2015
7
0.160
Why?
Physicians
2
2019
577
0.150
Why?
Patients
1
2016
87
0.150
Why?
Remission Induction
1
2017
700
0.150
Why?
Counseling
1
2016
130
0.150
Why?
Population Surveillance
1
2016
242
0.150
Why?
Carcinoma in Situ
1
2015
56
0.150
Why?
Selection Bias
1
2014
38
0.150
Why?
Immunohistochemistry
2
2010
1806
0.140
Why?
Chemoradiotherapy
1
2017
254
0.140
Why?
Cost-Benefit Analysis
1
2016
400
0.140
Why?
Linear Models
1
2015
424
0.140
Why?
Oropharyngeal Neoplasms
1
2015
80
0.140
Why?
Neoplasm Metastasis
1
2018
1037
0.140
Why?
Case-Control Studies
2
2018
1786
0.140
Why?
Adipokines
1
2013
22
0.140
Why?
Incidence
2
2017
1587
0.140
Why?
Insurance, Health
1
2014
146
0.130
Why?
Venous Thromboembolism
1
2015
113
0.130
Why?
Fatty Acids
1
2013
146
0.130
Why?
Kaplan-Meier Estimate
1
2015
903
0.130
Why?
Surgical Flaps
1
2015
261
0.120
Why?
Adipose Tissue
1
2013
253
0.110
Why?
Health Services Accessibility
1
2014
381
0.110
Why?
Head and Neck Neoplasms
1
2017
978
0.110
Why?
Reproducibility of Results
1
2017
2622
0.110
Why?
Models, Biological
1
2018
1787
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2015
1198
0.100
Why?
Calcium-Binding Proteins
1
2010
114
0.100
Why?
Intercellular Signaling Peptides and Proteins
1
2010
177
0.100
Why?
Hemostatics
1
2008
47
0.100
Why?
Receptor Cross-Talk
1
2008
32
0.100
Why?
False Positive Reactions
1
2008
224
0.090
Why?
African Americans
2
2017
1152
0.090
Why?
Neoplastic Cells, Circulating
1
2008
65
0.090
Why?
Interferon-alpha
1
2009
239
0.090
Why?
Hyperplasia
1
2008
153
0.090
Why?
Carcinoma, Squamous Cell
1
2015
1031
0.090
Why?
Biopsy, Needle
1
2008
269
0.090
Why?
Cancer Vaccines
1
2009
151
0.090
Why?
Chi-Square Distribution
1
2008
382
0.090
Why?
Immunologic Factors
1
2009
160
0.090
Why?
Drug Delivery Systems
1
2008
206
0.080
Why?
RNA, Messenger
1
2012
1974
0.080
Why?
Obesity
1
2013
928
0.080
Why?
Analysis of Variance
1
2008
954
0.080
Why?
Disease-Free Survival
2
2011
1195
0.080
Why?
Neoplasms
1
2018
2567
0.070
Why?
Sensitivity and Specificity
1
2008
2069
0.070
Why?
Membrane Proteins
1
2010
1187
0.070
Why?
Predictive Value of Tests
1
2008
1682
0.060
Why?
Mutation
1
2014
3779
0.060
Why?
Immunoenzyme Techniques
2
2013
328
0.060
Why?
Organizational Innovation
1
2020
35
0.050
Why?
Tumor Cells, Cultured
2
2013
1080
0.050
Why?
Fees and Charges
1
2018
13
0.050
Why?
Hospital Charges
1
2018
30
0.050
Why?
Program Evaluation
1
2020
303
0.050
Why?
Propensity Score
1
2018
135
0.050
Why?
Urologic Surgical Procedures
1
2018
98
0.040
Why?
Area Under Curve
1
2018
340
0.040
Why?
Postoperative Care
1
2017
234
0.040
Why?
Tumor Burden
1
2017
282
0.040
Why?
ROC Curve
1
2018
749
0.040
Why?
Chicago
1
2020
1416
0.040
Why?
Prostatectomy
1
2018
420
0.040
Why?
Self Report
1
2016
250
0.040
Why?
Cell Proliferation
2
2013
1596
0.040
Why?
Communication
1
2018
390
0.040
Why?
Blood Transfusion
1
2015
143
0.040
Why?
Prosthesis Failure
1
2015
146
0.040
Why?
Hispanic Americans
1
2017
388
0.040
Why?
Lipase
1
2013
23
0.030
Why?
Serpins
1
2013
28
0.030
Why?
Transplantation, Autologous
1
2015
321
0.030
Why?
Nerve Growth Factors
1
2013
68
0.030
Why?
Leptin
1
2013
113
0.030
Why?
Risk
1
2015
692
0.030
Why?
Physician-Patient Relations
1
2018
576
0.030
Why?
Ki-67 Antigen
1
2012
68
0.030
Why?
Microarray Analysis
1
2012
103
0.030
Why?
Eye Proteins
1
2013
128
0.030
Why?
In Situ Hybridization, Fluorescence
1
2012
356
0.030
Why?
Sepsis
1
2015
291
0.030
Why?
Comorbidity
1
2015
894
0.030
Why?
Body Mass Index
1
2013
757
0.030
Why?
Neoplasms, Hormone-Dependent
1
2008
39
0.020
Why?
Estradiol
1
2008
257
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
454
0.020
Why?
Mice, Nude
1
2008
777
0.020
Why?
RNA, Small Interfering
1
2008
570
0.020
Why?
Mice, Inbred BALB C
1
2008
1071
0.020
Why?
Mice
1
2008
10937
0.010
Why?
Animals
1
2008
26575
0.010
Why?
Yao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_